Voriconazole: a new triazole antifungal agent

LD Saravolatz, LB Johnson… - Clinical infectious …, 2003 - academic.oup.com
The 1990s witnessed an expansion of the antifungal armamentarium to include 2 new azole
agents, fluconazole and itraconazole. These agents changed our approach to treating many …

Current perspectives on ophthalmic mycoses

PA Thomas - Clinical microbiology reviews, 2003 - Am Soc Microbiol
Fungi may infect the cornea, orbit and other ocular structures. Species of Fusarium,
Aspergillus, Candida, dematiaceous fungi, and Scedosporium predominate. Diagnosis is …

Cutaneous Infection by Fusarium Species in Healthy and Immunocompromised Hosts: Implications for Diagnosis and Management

M Nucci, E Anaissie - Clinical Infectious Diseases, 2002 - academic.oup.com
Infections by Fusarium species frequently involve the skin, either as the primary or the
metastatic site. To better understand the pathophysiology of these infections, 43 new …

Voriconazole treatment for less-common, emerging, or refractory fungal infections

JR Perfect, KA Marr, TJ Walsh… - Clinical Infectious …, 2003 - academic.oup.com
Treatments for invasive fungal infections remain unsatisfactory. We evaluated the efficacy,
tolerability, and safety of voriconazole as salvage treatment for 273 patients with refractory …

Human fusariosis

MC Dignani, E Anaissie - Clinical Microbiology and Infection, 2004 - Wiley Online Library
Fusarium species frequently implicated in human infections include F. solani, F. oxysporum
and F. moniliforme. Among immunocompetent patients, tissue breakdown (as caused by …

Antifungal drug resistance to azoles and polyenes

MM Canuto, FG Rodero - The Lancet infectious diseases, 2002 - thelancet.com
There is an increased awareness of the morbidity and mortality associated with fungal
infections caused by resistant fungi in various groups of patients. Epidemiological studies …

Voriconazole

LA Jeu, FJ Piacenti, AG Lyakhovetskiy, HB Fung - Clinical therapeutics, 2003 - Elsevier
Background: Reports of resistance and intolerance to currently available antifungal agents
are increasing. Voriconazole is a broad-spectrum azole antifungal agent structurally derived …

Determination of vitreous, aqueous, and plasma concentration of OrallyAdministered voriconazole in humans

SM Hariprasad, WF Mieler, ER Holz… - Archives of …, 2004 - jamanetwork.com
Objective To investigate the penetration of voriconazole, a new-generation triazoleantifungal
agent, into the vitreous and aqueous humor after oral administration. Methods A prospective …

Voriconazole in the treatment of fungal eye infections: a review of current literature

SM Hariprasad, WF Mieler, TK Lin… - British Journal of …, 2008 - bjo.bmj.com
Background: Voriconazole has an important role to play in the prophylaxis and management
of fungal endophthalmitis and keratitis. New-generation triazoles, including voriconazole …

Endophthalmitis: a review of current evaluation and management

CA Lemley, DP Han - Retina, 2007 - journals.lww.com
Purpose: To review the current state of evaluation and management of various forms of
endophthalmitis. Methods: A review of the literature is included, encompassing …